Fosmanogepix is an Orally Active Gwt1 Inhibitor with Antifungal Activity
Invasive pulmonary aspergillosis (IPA) is the leading cause of mold infections in the immunocompromised host. Despite the current aggressive antifungal therapy, IPA still results in a high percentage of fatalities…
